Skip to Content

S 200 197 (Morphine Sulfate Extended-Release 200 mg)

Pill with imprint S 200 197 is Green, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 200 mg. It is supplied by Sun Pharmaceutical Industries, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for S 200 197

Morphine Sulfate Extended-Release

Imprint
S 200 197
Strength
200 mg
Color
Green
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Sun Pharmaceutical Industries, Inc.
National Drug Code (NDC)
57664-0197
Inactive Ingredients
lactose monohydrate, hypromelloses, hydroxyethyl cellulose (2000 mpa.s at 1%), magnesium stearate, stearic acid, butylated hydroxyanisole, butylated hydroxytoluene, polyethylene glycol 400, titanium dioxide, polysorbate 80, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.